Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Foventa Therapeutics Appoints Dr Zaiba Malik As Chief Medical Officer and Julia Jones As Chief Financial Officer

PRIVATESep 02, 2026•5 days ago

Position

Chief Financial Officer

Company

Foventa Therapeutics

Julia Jones
CambridgeBiotechnologyHealth CareTherapeutics

Description

Foventa Therapeutics has announced the appointment of Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer. They will work alongside the newly appointed CEO Olav Hellebø to advance FOV407 through its Phase IIb trial and secure funding.

Company Information

Company

Foventa Therapeutics

Location

Cambridge, England, United Kingdom

About

Foventa Therapeutics is a clinical-stage biotechnology company dedicated to preserving sight through the development of innovative ophthalmic medicines. Our lead programme, FOV407, is being developed as a topical eye drop for non-proliferative diabetic retinopathy (NPDR), a common complication of diabetes that can lead to irreversible vision loss. Unlike current treatments, FOV407 offers a non-invasive approach that could enable earlier intervention.

Don't miss Foventa Therapeutics's next move

Get an email the moment Foventa Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Foventa Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Foventa Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.